BTLA(CD272), Fc fusion (Human)

Catalog #: 71141
Size: 100 µg
$310
Species: Human
Host Species: HEK293
MW: 40.3 kDa
Genbank #: NM_181780
Tag(s): C-terminal Fc fusion (Human IgG1)
a.a: 31-150
Description:

Human B- and T-lymphocyte attenuator (BTLA)-Fc fusion protein, also known as CD272, GenBank Accession No. NM_181780, a.a. 31-150, expressed in a HEK293 cell expression system. MW = 40.3 kDa (monomer). This protein runs at a higher apparent M.W. by SDS-PAGE due to glycosylation.

UniProt
Q7Z6A9
Synonym(s):
CD272
Endotoxin Level:

<1 EU/µg

Formulation:
40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol
Format:
Aqueous buffer solution
Storage / Stability:
At least 6 months at –80°C.
Application(s):
Useful for the study of protein-protein interaction and in vitro and in vivo protein function studies.
Reference(s):

1. Flynn R, et al., PLoS One. 2013 Oct 29;8(10):77991.

2. Uchiyama M, et al., Transplantaion. 2014 Feb 15;97(3):301-9.

Notes:
The aggregation state of this product has been confirmed to be <10%.
Warning(s):
Avoid freeze/thaw cycles. Protein may be diluted to ≥ 100 μg/ml in PBS + glycerol and stored at -80°C.
Scientific Category:
Immunotherapy
Product Type:
Recombinant Protein
Data shown is lot-specific. Contact us for specific information on other lots.

Quality Assurance

Product Datasheets

71141_BTLA_Lot151201_R.pdf